Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.05.2012 | Case report

Adalimumab/tocilizumab

Leucocytoclastic vasculitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Khan M, Saeed A, Elmamoun M, Mumtaz E, Morrissey S, Brady M, Fraser A.Severe leucocytoclastic vasculitis with digital gangrene and amputation occurring in the same patient from anti-TNF and anti-IL6. Irish Journal of Medical Science 180: S203, Jun 2011. Available from: URL: http://dx.doi.org/10.1007/s11845-011-0715-3 - Ireland Khan M, Saeed A, Elmamoun M, Mumtaz E, Morrissey S, Brady M, Fraser A.Severe leucocytoclastic vasculitis with digital gangrene and amputation occurring in the same patient from anti-TNF and anti-IL6. Irish Journal of Medical Science 180: S203, Jun 2011. Available from: URL: http://​dx.​doi.​org/​10.​1007/​s11845-011-0715-3 - Ireland
Metadaten
Titel
Adalimumab/tocilizumab
Leucocytoclastic vasculitis: case report
Publikationsdatum
01.05.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214020-00018

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Triamcinolone

Case report

Dapsone